You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T cell product

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study of Participants Who ReceivedAllogeneic CAR T-Cell Product

Recruiting
  • Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
    • Culver City, California
      Science 37, Inc.
    Apr 10, 2023

    NSCLC Trial (KB-GDT-01)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • KB-GDT-01
    • (no location specified)
    Sep 29, 2023

    Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

    Recruiting
    • Liver Carcinoma
    • Hepatic Cell Carcinoma
    • CAR-GPC3 T cells
    • Wuhan, Hubei, China
      Tao Zhang
    Nov 20, 2023

    Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

    Recruiting
    • Multiple Myeloma
    • Autologous hematopoietic stem cell transplantation
    • C-CAR088
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 21, 2022

    DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,

    Not yet recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • +6 more
    • Bridging radiation therapy
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)

    Recruiting
    • Acute Myeloid Leukemia in Children
    • CIML NK Cell Infusion
    • CD3+ T Cell Product Infusion
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 26, 2022

    B-Cell Lymphoma, B Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Pittsburgh (Chimeric Antigen Receptor

    Recruiting
    • B-Cell Lymphoma
    • +8 more
    • Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
    • Pittsburgh, Pennsylvania
      AHN Cancer Institute - West Penn Hospital
    Aug 10, 2022

    Breast Cancer, Colorectal Cancer, Uveal Melanoma Trial in Orlando, Pittsburgh (TBio-4101, Pembrolizumab)

    Recruiting
    • Breast Cancer
    • +2 more
    • Orlando, Florida
    • +1 more
    Feb 1, 2023

    Non-Hodgkin Lymphoma, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in United States (radiation,

    Recruiting
    • Non-Hodgkin Lymphoma
    • +2 more
    • Bridging radiotherapy (BRT)
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 24, 2023

    Patients Previously Treated WithMustang Bio CAR-T Cell

    Enrolling by invitation
    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    • +10 more
    • Prior MB-102 CAR-T cell investigational product.
    • Prior MB-106 CAR-T cell investigational product.
    • Duarte, California
    • +4 more
    Dec 8, 2022

    Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

    Recruiting
    • Hepatocellular Carcinoma
    • +3 more
    • ET140203 autologous T cell product
    • Duarte, California
    • +3 more
    Jul 1, 2022

    Subjects Treated With ACTR T Cell Product

    Terminated
    • B Cell Lymphomas
    • +3 more
    • ACTR T Cell Product
    • Gilbert, Arizona
    • +15 more
    Oct 4, 2021

    Subjects Treated With Autologous T Cells Using Sleeping Beauty

    Not yet recruiting
    • Gynecologic Cancer
    • +9 more
    • Neoantigen specific TCR-T cell drug product
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)

    Not yet recruiting
    • Extramedullary Myeloma
    • Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    Dec 18, 2022

    Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

    Recruiting
    • Gynecologic Cancer
    • +11 more
    • Neoantigen specific TCR-T cell drug product
    • Aldesleukin (IL-2)
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)

    Not yet recruiting
    • Cytomegalovirus
    • Adenovirus
    • VST infusion
    • CliniMACS
    • Memphis, Tennessee
      St . Jude Children's Research Hospital
    Jan 9, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory Trial in Memphis (drug, device, biological)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • Acute Lymphoblastic Leukemia, Refractory
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jan 3, 2023

    Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

    Not yet recruiting
    • Allogeneic Stem Cell Transplant Candidate
    • +4 more
    • Cellular therapy product
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 1, 2022

    Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jul 6, 2022

    Solid Tumors Trial in Hefei, Shanghai (LCAR-C18S cells)

    Recruiting
    • Solid Tumors
    • LCAR-C18S cells
    • Hefei, Anhui, China
    • +2 more
    Jun 17, 2022

    Diffuse Large B Cell Lymphoma (DLBCL) Trial in Denver, Nashville (bbT369)

    Recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • bbT369
    • Denver, Colorado
    • +1 more
    Feb 10, 2022

    Multiple Myeloma Trial in New York (busulfan, melphalan and fludarabine)

    Completed
    Has Results
    • Multiple Myeloma
    • busulfan, melphalan and fludarabine
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 4, 2021

    Lymphoma Trial in United States (ACTR707, rituximab)

    Terminated
    • Lymphoma
    • ACTR707
    • rituximab
    • Gilbert, Arizona
    • +10 more
    Oct 4, 2021

    Sarcoma, HER-2 Protein Overexpression Trial in Houston (cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product)

    Recruiting
    • Sarcoma
    • HER-2 Protein Overexpression
    • cells
    • +3 more
    • Houston, Texas
      Texas Children's Hospital
    Dec 8, 2021

    Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in Duarte, Irvine, Sacramento (ET140202 autologous T cell product)

    Terminated
    • Hepatocellular Carcinoma
    • +3 more
    • ET140202 autologous T cell product
    • Duarte, California
    • +2 more
    Apr 14, 2021